Skip to main content

PetVivo Holdings, Inc.

corporate_fare Company Profile

PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Exchange: OTCSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed PETV - Latest Insights

PETV
Apr 17, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
PETV
Mar 16, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
PETV
Mar 13, 2026, 5:10 PM EDT
Filing Type: 4
Importance Score:
9
PETV
Mar 13, 2026, 5:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
PETV
Feb 17, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
9
PETV
Jan 22, 2026, 1:06 PM EST
Filing Type: 8-K
Importance Score:
7
PETV
Jan 16, 2026, 4:41 PM EST
Filing Type: 5
Importance Score:
8
PETV
Jan 16, 2026, 4:40 PM EST
Filing Type: 5
Importance Score:
7
PETV
Jan 16, 2026, 4:39 PM EST
Filing Type: 5
Importance Score:
8
PETV
Jan 16, 2026, 4:30 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
8